India Trial Sought for Novavax Covid Vaccine | Read

PUBLISHED ON: January 29, 2021 | Duration: 0 min, 34 sec

  
loading..
The Serum Institute of India, the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of American vaccine developer Novavax's COVID-19 jab, which was found to be 89.3 per cent effective in a UK trial. It was also found to be highly effective against a variant first identified in the UK. But the positive Phase 3 clinical trial data was partly offset by other results that showed it offered significantly less protection against a highly transmissible variant of the coronavirus first identified in South Africa, which is spreading rapidly around the world.
ALSO WATCH
COVID-19 Impact On Health & Nutrition Of Women & Children

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com